Perimenstrual Asthma and Premenstrual Disorders in Adolescents with Asthma

Abstract

IntroductionAsthma is a common chronic disease in pediatric patients, and perimenstrual asthma (PMA) refers to the worsening of asthma symptoms during the perimenstrual period, mainly reported in adult women. However, there is limited information regarding the exacerbation of symptoms in the presence of premenstrual disorders (PMDs) in adolescents. This pilot observational study aims to investigate the frequency and potential association of PMA and PMDs in a clinical sample of adolescents with asthma. Patients and MethodsThe study included 50 adolescents (aged 12-18 years, mean 16.08 ± 2.35) with asthma and at least 2 years of gynecological age. The participants completed the Asthma Control Test (ACT) to assess asthma control (considered pathological if ACT score<20) and the modified Premenstrual Symptoms Screening Tool for Adolescents (PSST-A) to evaluate PMDs. ResultsA total of 75.5% of adolescents reported PMA. The prevalence of premenstrual symptoms did not significantly differ between the PMA and no-PMA group. Among the study sample, 38.7% experienced symptoms indicative of moderate/severe premenstrual syndrome (PMS), and 8.1% exhibited symptoms of premenstrual dysphoric disorder (PMDD). Compared to no-PMA group, patients with PMA showed a significant impairment in daily and home activities (p=0.03 and p=0.02, respectively) and exhibited a difference in the frequency of asthma symptoms (p<0.001) and medication use (p=<0.01). ConclusionsPerimenstrual worsening of asthma symptoms may be common in adolescents with severe form of asthma. Prospective data collection through menstrual diaries is necessary to further explore the association between PMA and PMDs. Identifying early risk factors for PMA could facilitate the development of preventive strategies and early interventions for adolescents with asthma.